Go beyond the surface with Medicann Insights — a space where we share what drives us, how we support our patients, and why our approach to medical cannabis care sets us apart. Real insight. Real care. Real people.
Each week, the conversation around medicinal cannabis continues to grow as new patient stories, research and policy discussions highlight how this treatment is changing lives. From individuals managing long-term conditions to campaigns pushing for greater awareness and access, the evidence and experiences emerging across the UK continue to shape the future of care. This week’s roundup explores a powerful patient story about living with multiple sclerosis, how medicinal cannabis has helped manage a chronic skin condition and a campaign honouring the legacy of Hannah Deacon, a dear friend of Medicann’s, who played a role in changing UK cannabis law.
Read More
This week’s Medicinal Cannabis Matters brings together developments in patient education, regulatory accountability and international market recovery. From practical guidance on pain relief for arthritis to important conversations about clinical responsibility, the wider landscape continues to mature in both structure and understanding.
Read More
This week’s Medicinal Cannabis Matters reflects a growing maturity in the medicinal cannabis industry, both in the UK and across Europe. From clearer understanding of UK regulation, to formal medical education in cannabis medicine and long-awaited reimbursement framework in France, the conversation continues to shift towards patient-centred progress.
Read More
This week’s Medicinal Cannabis Matters brings together powerful patient stories and emerging data that continue to shape the future of medicinal cannabis care in the UK. From lived experience in the Scottish Borders to national media coverage and new survey findings among cancer patients, the focus remains firmly on quality of life and informed access.
Read More
Welcome to this week’s round-up in medicinal cannabis, where emerging research and patient-focused discussion continue to shape a more informed understanding of medicinal cannabis care. This week’s stories explore how low-dose cannabinoids are being studied in neurodegenerative disease, what new research says about cannabis use and brain health in later life and why clearer guidance around lawful use remains essential for patients in the UK.
Read More
Welcome to this week’s Medicinal Cannabis Matters, where we’re exploring the latest stories shaping access and acceptance of medicinal cannabis across the UK. As awareness grows, specialist care is increasingly being recognised as a vital addition to existing NHS services, particularly for patients whose needs are not being fully met.
Read More